 | • レポートコード：QYR2104Z2950 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、126ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、ヒト免疫不全ウイルス検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗体検査、RNA（ウイルス量）検査、抗体抗原検査）、用途別市場規模（診断センター、病院、家庭用）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・ヒト免疫不全ウイルス検査の市場動向 ・企業の競争状況、市場シェア ・ヒト免疫不全ウイルス検査の種類別市場規模（抗体検査、RNA（ウイルス量）検査、抗体抗原検査） ・ヒト免疫不全ウイルス検査の用途別市場規模（診断センター、病院、家庭用） ・ヒト免疫不全ウイルス検査の北米市場規模2016-2027（アメリカ、カナダ） ・ヒト免疫不全ウイルス検査のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・ヒト免疫不全ウイルス検査のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・ヒト免疫不全ウイルス検査の中南米市場規模2016-2027（メキシコ、ブラジル） ・ヒト免疫不全ウイルス検査の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Abbott、Bio-Rad、WanTai BioPharm、Beckman Coulter、BD、Kehua、Livzon、Intec、ThermoFisher、Biokit、Nectar Lifesciences、ELITech Group、Chembio Diagnostic Systems、Trinity Biotech） ・結論 |
Human Immunodeficiency Virus Testing is the procedure to test if the patient have the Human Immunodeficiency Virus
Market Analysis and Insights: Global Human Immunodeficiency Virus Testing Market
The global Human Immunodeficiency Virus Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Human Immunodeficiency Virus Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Human Immunodeficiency Virus Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Human Immunodeficiency Virus Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Human Immunodeficiency Virus Testing market.
Global Human Immunodeficiency Virus Testing Scope and Market Size
Human Immunodeficiency Virus Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Immunodeficiency Virus Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Antibody Tests
RNA (viral load) Test
Antibody-antigen Test
Segment by Application
Diagnostic Centers
Hospitals
Home Use
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Abbott
Bio-Rad
WanTai BioPharm
Beckman Coulter
BD
Kehua
Livzon
Intec
WanTai BioPharm
Beckman Coulter
Nectar Lifesciences
ELITech Group
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Human Immunodeficiency Virus Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Antibody Tests
1.2.3 RNA (viral load) Test
1.2.4 Antibody-antigen Test
1.3 Market by Application
1.3.1 Global Human Immunodeficiency Virus Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Diagnostic Centers
1.3.3 Hospitals
1.3.4 Home Use
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Human Immunodeficiency Virus Testing Market Perspective (2016-2027)
2.2 Human Immunodeficiency Virus Testing Growth Trends by Regions
2.2.1 Human Immunodeficiency Virus Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Human Immunodeficiency Virus Testing Historic Market Share by Regions (2016-2021)
2.2.3 Human Immunodeficiency Virus Testing Forecasted Market Size by Regions (2022-2027)
2.3 Human Immunodeficiency Virus Testing Industry Dynamic
2.3.1 Human Immunodeficiency Virus Testing Market Trends
2.3.2 Human Immunodeficiency Virus Testing Market Drivers
2.3.3 Human Immunodeficiency Virus Testing Market Challenges
2.3.4 Human Immunodeficiency Virus Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Human Immunodeficiency Virus Testing Players by Revenue
3.1.1 Global Top Human Immunodeficiency Virus Testing Players by Revenue (2016-2021)
3.1.2 Global Human Immunodeficiency Virus Testing Revenue Market Share by Players (2016-2021)
3.2 Global Human Immunodeficiency Virus Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Human Immunodeficiency Virus Testing Revenue
3.4 Global Human Immunodeficiency Virus Testing Market Concentration Ratio
3.4.1 Global Human Immunodeficiency Virus Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Human Immunodeficiency Virus Testing Revenue in 2020
3.5 Human Immunodeficiency Virus Testing Key Players Head office and Area Served
3.6 Key Players Human Immunodeficiency Virus Testing Product Solution and Service
3.7 Date of Enter into Human Immunodeficiency Virus Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Human Immunodeficiency Virus Testing Breakdown Data by Type
4.1 Global Human Immunodeficiency Virus Testing Historic Market Size by Type (2016-2021)
4.2 Global Human Immunodeficiency Virus Testing Forecasted Market Size by Type (2022-2027)
5 Human Immunodeficiency Virus Testing Breakdown Data by Application
5.1 Global Human Immunodeficiency Virus Testing Historic Market Size by Application (2016-2021)
5.2 Global Human Immunodeficiency Virus Testing Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Human Immunodeficiency Virus Testing Market Size (2016-2027)
6.2 North America Human Immunodeficiency Virus Testing Market Size by Type
6.2.1 North America Human Immunodeficiency Virus Testing Market Size by Type (2016-2021)
6.2.2 North America Human Immunodeficiency Virus Testing Market Size by Type (2022-2027)
6.2.3 North America Human Immunodeficiency Virus Testing Market Size by Type (2016-2027)
6.3 North America Human Immunodeficiency Virus Testing Market Size by Application
6.3.1 North America Human Immunodeficiency Virus Testing Market Size by Application (2016-2021)
6.3.2 North America Human Immunodeficiency Virus Testing Market Size by Application (2022-2027)
6.3.3 North America Human Immunodeficiency Virus Testing Market Size by Application (2016-2027)
6.4 North America Human Immunodeficiency Virus Testing Market Size by Country
6.4.1 North America Human Immunodeficiency Virus Testing Market Size by Country (2016-2021)
6.4.2 North America Human Immunodeficiency Virus Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Human Immunodeficiency Virus Testing Market Size (2016-2027)
7.2 Europe Human Immunodeficiency Virus Testing Market Size by Type
7.2.1 Europe Human Immunodeficiency Virus Testing Market Size by Type (2016-2021)
7.2.2 Europe Human Immunodeficiency Virus Testing Market Size by Type (2022-2027)
7.2.3 Europe Human Immunodeficiency Virus Testing Market Size by Type (2016-2027)
7.3 Europe Human Immunodeficiency Virus Testing Market Size by Application
7.3.1 Europe Human Immunodeficiency Virus Testing Market Size by Application (2016-2021)
7.3.2 Europe Human Immunodeficiency Virus Testing Market Size by Application (2022-2027)
7.3.3 Europe Human Immunodeficiency Virus Testing Market Size by Application (2016-2027)
7.4 Europe Human Immunodeficiency Virus Testing Market Size by Country
7.4.1 Europe Human Immunodeficiency Virus Testing Market Size by Country (2016-2021)
7.4.2 Europe Human Immunodeficiency Virus Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Human Immunodeficiency Virus Testing Market Size (2016-2027)
8.2 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Type
8.2.1 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Application
8.3.1 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Region
8.4.1 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Human Immunodeficiency Virus Testing Market Size (2016-2027)
9.2 Latin America Human Immunodeficiency Virus Testing Market Size by Type
9.2.1 Latin America Human Immunodeficiency Virus Testing Market Size by Type (2016-2021)
9.2.2 Latin America Human Immunodeficiency Virus Testing Market Size by Type (2022-2027)
9.2.3 Latin America Human Immunodeficiency Virus Testing Market Size by Type (2016-2027)
9.3 Latin America Human Immunodeficiency Virus Testing Market Size by Application
9.3.1 Latin America Human Immunodeficiency Virus Testing Market Size by Application (2016-2021)
9.3.2 Latin America Human Immunodeficiency Virus Testing Market Size by Application (2022-2027)
9.3.3 Latin America Human Immunodeficiency Virus Testing Market Size by Application (2016-2027)
9.4 Latin America Human Immunodeficiency Virus Testing Market Size by Country
9.4.1 Latin America Human Immunodeficiency Virus Testing Market Size by Country (2016-2021)
9.4.2 Latin America Human Immunodeficiency Virus Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Human Immunodeficiency Virus Testing Market Size (2016-2027)
10.2 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Type
10.2.1 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Application
10.3.1 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Country
10.4.1 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Human Immunodeficiency Virus Testing Introduction
11.1.4 Roche Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Human Immunodeficiency Virus Testing Introduction
11.2.4 Abbott Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.2.5 Abbott Recent Development
11.3 Bio-Rad
11.3.1 Bio-Rad Company Details
11.3.2 Bio-Rad Business Overview
11.3.3 Bio-Rad Human Immunodeficiency Virus Testing Introduction
11.3.4 Bio-Rad Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.3.5 Bio-Rad Recent Development
11.4 WanTai BioPharm
11.4.1 WanTai BioPharm Company Details
11.4.2 WanTai BioPharm Business Overview
11.4.3 WanTai BioPharm Human Immunodeficiency Virus Testing Introduction
11.4.4 WanTai BioPharm Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.4.5 WanTai BioPharm Recent Development
11.5 Beckman Coulter
11.5.1 Beckman Coulter Company Details
11.5.2 Beckman Coulter Business Overview
11.5.3 Beckman Coulter Human Immunodeficiency Virus Testing Introduction
11.5.4 Beckman Coulter Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.5.5 Beckman Coulter Recent Development
11.6 BD
11.6.1 BD Company Details
11.6.2 BD Business Overview
11.6.3 BD Human Immunodeficiency Virus Testing Introduction
11.6.4 BD Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.6.5 BD Recent Development
11.7 Kehua
11.7.1 Kehua Company Details
11.7.2 Kehua Business Overview
11.7.3 Kehua Human Immunodeficiency Virus Testing Introduction
11.7.4 Kehua Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.7.5 Kehua Recent Development
11.8 Livzon
11.8.1 Livzon Company Details
11.8.2 Livzon Business Overview
11.8.3 Livzon Human Immunodeficiency Virus Testing Introduction
11.8.4 Livzon Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.8.5 Livzon Recent Development
11.9 Intec
11.9.1 Intec Company Details
11.9.2 Intec Business Overview
11.9.3 Intec Human Immunodeficiency Virus Testing Introduction
11.9.4 Intec Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.9.5 Intec Recent Development
11.10 ThermoFisher
11.10.1 ThermoFisher Company Details
11.10.2 ThermoFisher Business Overview
11.10.3 ThermoFisher Human Immunodeficiency Virus Testing Introduction
11.10.4 ThermoFisher Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.10.5 ThermoFisher Recent Development
11.11 Biokit
11.11.1 Biokit Company Details
11.11.2 Biokit Business Overview
11.11.3 Biokit Human Immunodeficiency Virus Testing Introduction
11.11.4 Biokit Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.11.5 Biokit Recent Development
11.12 Nectar Lifesciences
11.12.1 Nectar Lifesciences Company Details
11.12.2 Nectar Lifesciences Business Overview
11.12.3 Nectar Lifesciences Human Immunodeficiency Virus Testing Introduction
11.12.4 Nectar Lifesciences Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.12.5 Nectar Lifesciences Recent Development
11.13 ELITech Group
11.13.1 ELITech Group Company Details
11.13.2 ELITech Group Business Overview
11.13.3 ELITech Group Human Immunodeficiency Virus Testing Introduction
11.13.4 ELITech Group Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.13.5 ELITech Group Recent Development
11.14 Chembio Diagnostic Systems
11.14.1 Chembio Diagnostic Systems Company Details
11.14.2 Chembio Diagnostic Systems Business Overview
11.14.3 Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Introduction
11.14.4 Chembio Diagnostic Systems Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.14.5 Chembio Diagnostic Systems Recent Development
11.15 Trinity Biotech
11.15.1 Trinity Biotech Company Details
11.15.2 Trinity Biotech Business Overview
11.15.3 Trinity Biotech Human Immunodeficiency Virus Testing Introduction
11.15.4 Trinity Biotech Revenue in Human Immunodeficiency Virus Testing Business (2016-2021)
11.15.5 Trinity Biotech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Human Immunodeficiency Virus Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Antibody Tests
Table 3. Key Players of RNA (viral load) Test
Table 4. Key Players of Antibody-antigen Test
Table 5. Global Human Immunodeficiency Virus Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Human Immunodeficiency Virus Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Human Immunodeficiency Virus Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Human Immunodeficiency Virus Testing Market Share by Regions (2016-2021)
Table 9. Global Human Immunodeficiency Virus Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Human Immunodeficiency Virus Testing Market Share by Regions (2022-2027)
Table 11. Human Immunodeficiency Virus Testing Market Trends
Table 12. Human Immunodeficiency Virus Testing Market Drivers
Table 13. Human Immunodeficiency Virus Testing Market Challenges
Table 14. Human Immunodeficiency Virus Testing Market Restraints
Table 15. Global Human Immunodeficiency Virus Testing Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Human Immunodeficiency Virus Testing Market Share by Players (2016-2021)
Table 17. Global Top Human Immunodeficiency Virus Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus Testing as of 2020)
Table 18. Ranking of Global Top Human Immunodeficiency Virus Testing Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Human Immunodeficiency Virus Testing Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Human Immunodeficiency Virus Testing Product Solution and Service
Table 22. Date of Enter into Human Immunodeficiency Virus Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Human Immunodeficiency Virus Testing Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Human Immunodeficiency Virus Testing Revenue Market Share by Type (2016-2021)
Table 26. Global Human Immunodeficiency Virus Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Human Immunodeficiency Virus Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Human Immunodeficiency Virus Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Human Immunodeficiency Virus Testing Revenue Market Share by Application (2016-2021)
Table 30. Global Human Immunodeficiency Virus Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Human Immunodeficiency Virus Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Human Immunodeficiency Virus Testing Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Human Immunodeficiency Virus Testing Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Human Immunodeficiency Virus Testing Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Human Immunodeficiency Virus Testing Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Human Immunodeficiency Virus Testing Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Human Immunodeficiency Virus Testing Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Human Immunodeficiency Virus Testing Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Human Immunodeficiency Virus Testing Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Human Immunodeficiency Virus Testing Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Human Immunodeficiency Virus Testing Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Human Immunodeficiency Virus Testing Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Human Immunodeficiency Virus Testing Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Human Immunodeficiency Virus Testing Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Human Immunodeficiency Virus Testing Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Human Immunodeficiency Virus Testing Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Human Immunodeficiency Virus Testing Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Human Immunodeficiency Virus Testing Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Human Immunodeficiency Virus Testing Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Human Immunodeficiency Virus Testing Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Human Immunodeficiency Virus Testing Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Human Immunodeficiency Virus Testing Product
Table 65. Roche Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Abbott Company Details
Table 68. Abbott Business Overview
Table 69. Abbott Human Immunodeficiency Virus Testing Product
Table 70. Abbott Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 71. Abbott Recent Development
Table 72. Bio-Rad Company Details
Table 73. Bio-Rad Business Overview
Table 74. Bio-Rad Human Immunodeficiency Virus Testing Product
Table 75. Bio-Rad Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 76. Bio-Rad Recent Development
Table 77. WanTai BioPharm Company Details
Table 78. WanTai BioPharm Business Overview
Table 79. WanTai BioPharm Human Immunodeficiency Virus Testing Product
Table 80. WanTai BioPharm Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 81. WanTai BioPharm Recent Development
Table 82. Beckman Coulter Company Details
Table 83. Beckman Coulter Business Overview
Table 84. Beckman Coulter Human Immunodeficiency Virus Testing Product
Table 85. Beckman Coulter Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 86. Beckman Coulter Recent Development
Table 87. BD Company Details
Table 88. BD Business Overview
Table 89. BD Human Immunodeficiency Virus Testing Product
Table 90. BD Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 91. BD Recent Development
Table 92. Kehua Company Details
Table 93. Kehua Business Overview
Table 94. Kehua Human Immunodeficiency Virus Testing Product
Table 95. Kehua Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 96. Kehua Recent Development
Table 97. Livzon Company Details
Table 98. Livzon Business Overview
Table 99. Livzon Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 100. Livzon Recent Development
Table 101. Intec Company Details
Table 102. Intec Business Overview
Table 103. Intec Human Immunodeficiency Virus Testing Product
Table 104. Intec Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 105. Intec Recent Development
Table 106. ThermoFisher Company Details
Table 107. ThermoFisher Business Overview
Table 108. ThermoFisher Human Immunodeficiency Virus Testing Product
Table 109. ThermoFisher Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 110. ThermoFisher Recent Development
Table 111. Biokit Company Details
Table 112. Biokit Business Overview
Table 113. Biokit Human Immunodeficiency Virus Testing Product
Table 114. Biokit Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 115. Biokit Recent Development
Table 116. Nectar Lifesciences Company Details
Table 117. Nectar Lifesciences Business Overview
Table 118. Nectar Lifesciences Human Immunodeficiency Virus Testing Product
Table 119. Nectar Lifesciences Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 120. Nectar Lifesciences Recent Development
Table 121. ELITech Group Company Details
Table 122. ELITech Group Business Overview
Table 123. ELITech Group Human Immunodeficiency Virus Testing Product
Table 124. ELITech Group Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 125. ELITech Group Recent Development
Table 126. Chembio Diagnostic Systems Company Details
Table 127. Chembio Diagnostic Systems Business Overview
Table 128. Chembio Diagnostic Systems Human Immunodeficiency Virus Testing Product
Table 129. Chembio Diagnostic Systems Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 130. Chembio Diagnostic Systems Recent Development
Table 131. Trinity Biotech Company Details
Table 132. Trinity Biotech Business Overview
Table 133. Trinity Biotech Human Immunodeficiency Virus Testing Product
Table 134. Trinity Biotech Revenue in Human Immunodeficiency Virus Testing Business (2016-2021) & (US$ Million)
Table 135. Trinity Biotech Recent Development
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Human Immunodeficiency Virus Testing Market Share by Type: 2020 VS 2027
Figure 2. Antibody Tests Features
Figure 3. RNA (viral load) Test Features
Figure 4. Antibody-antigen Test Features
Figure 5. Global Human Immunodeficiency Virus Testing Market Share by Application: 2020 VS 2027
Figure 6. Diagnostic Centers Case Studies
Figure 7. Hospitals Case Studies
Figure 8. Home Use Case Studies
Figure 9. Human Immunodeficiency Virus Testing Report Years Considered
Figure 10. Global Human Immunodeficiency Virus Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Human Immunodeficiency Virus Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Human Immunodeficiency Virus Testing Market Share by Regions: 2020 VS 2027
Figure 13. Global Human Immunodeficiency Virus Testing Market Share by Regions (2022-2027)
Figure 14. Global Human Immunodeficiency Virus Testing Market Share by Players in 2020
Figure 15. Global Top Human Immunodeficiency Virus Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Immunodeficiency Virus Testing as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Human Immunodeficiency Virus Testing Revenue in 2020
Figure 17. Global Human Immunodeficiency Virus Testing Revenue Market Share by Type (2016-2021)
Figure 18. Global Human Immunodeficiency Virus Testing Revenue Market Share by Type (2022-2027)
Figure 19. North America Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Human Immunodeficiency Virus Testing Market Share by Type (2016-2027)
Figure 21. North America Human Immunodeficiency Virus Testing Market Share by Application (2016-2027)
Figure 22. North America Human Immunodeficiency Virus Testing Market Share by Country (2016-2027)
Figure 23. United States Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Human Immunodeficiency Virus Testing Market Share by Type (2016-2027)
Figure 27. Europe Human Immunodeficiency Virus Testing Market Share by Application (2016-2027)
Figure 28. Europe Human Immunodeficiency Virus Testing Market Share by Country (2016-2027)
Figure 29. Germany Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Human Immunodeficiency Virus Testing Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Human Immunodeficiency Virus Testing Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Human Immunodeficiency Virus Testing Market Share by Region (2016-2027)
Figure 39. China Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Human Immunodeficiency Virus Testing Market Share by Type (2016-2027)
Figure 47. Latin America Human Immunodeficiency Virus Testing Market Share by Application (2016-2027)
Figure 48. Latin America Human Immunodeficiency Virus Testing Market Share by Country (2016-2027)
Figure 49. Mexico Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Human Immunodeficiency Virus Testing Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Human Immunodeficiency Virus Testing Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Human Immunodeficiency Virus Testing Market Share by Country (2016-2027)
Figure 55. Turkey Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Human Immunodeficiency Virus Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Roche Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 59. Abbott Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 60. Bio-Rad Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 61. WanTai BioPharm Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 62. Beckman Coulter Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 63. BD Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 64. Kehua Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 65. Livzon Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 66. Intec Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 67. ThermoFisher Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 68. Biokit Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 69. Nectar Lifesciences Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 70. ELITech Group Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 71. Chembio Diagnostic Systems Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 72. Trinity Biotech Revenue Growth Rate in Human Immunodeficiency Virus Testing Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界のヒト免疫不全ウイルス（HIV）市場規模・現状・予測（2021年-2027年） HIV (Human immunodeficiency virus) is a retrovirus which causes HIV infection and attacks the CD-4 cells (T-cells) in the immune system of human body. HIV reduces the number of T-cells in the body and makes the immune system vulnerable to life-threatening infections and cancers. An infected person c…- 世界のヒト免疫不全ウイルス（HIV）-1治療市場規模・現状・予測（2021年-2027年） The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS).AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and can…
- 世界のヒトパピローマウイルス検査市場規模・現状・予測（2021年-2027年） HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. The increasing incidence rate of cervical and vaginal cancer is the key driver for the market growth. Market Analysis and Insights: Global Human papilloma virus Testing M…
- 世界のヒトパピローマウイルス検査市場規模・現状・予測（2021年-2027年） HPV testing and Pap test market has been divided into two major segments on basis of test type, namely, HPV testing and Pap test. The increasing incidence rate of cervical and vaginal cancer is the key driver for the market growth. Market Analysis and Insights: Global Human papilloma virus Testing M…
- 世界のC型肝炎ウイルス（HCV）検査市場規模・現状・予測（2021年-2027年） Hepatitis C Virus (HCV) Testing is the procedure to test if the patient have the Hepatitis C Virus. Market Analysis and Insights: Global Hepatitis C Virus (HCV) Testing Market The global Hepatitis C Virus (HCV) Testing market size is projected to reach US$ XX million by 2026, from US$ XX million in …